Vestita, Michelangelo <br/><br/>
Vismodegib and risk of cholestatic injury: should we screen candidate patients?  [electronic resource] 

 -  Clinical and experimental medicine  08 2017 
 - 415-416 p.  digital 
<br/><br/> Publication Type: Letter; Comment 
<br/><br/><label>ISSN: </label>1591-9528 
<br/><br/><label>Standard No.: </label>10.1007/s10238-016-0433-2  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anilides<br/>Antineoplastic Agents<br/>Humans<br/>Pyridines<br/>Skin Neoplasms